Phase 2b study of PA101 for the treatment of refractory chronic cough with idiopathic pulmonary fibrosis.
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2016
At a glance
- Drugs Sodium cromoglicate (Primary)
- Indications Cough; Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 28 Sep 2016 New trial record
- 07 Sep 2016 Based on the results from other Phase II trial (see profile 254592) company is planning to start this trial in early 2017, as reported by Patara Pharma media release.